Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CODEXIS, INC. | 314,125 | reported | 01 Jan 2024 | tx 5+862,553 |
| Caribou Biosciences, Inc. | 247,500 | reported | 20 Feb 2026 | tx 4+619,860 |
| Celladon Corp | 41,566 | reported | 14 Mar 2022 | tx 12+554,378−2,266 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2026 | GRANT_AWARD | Caribou Biosciences, Inc. | 55,000 | 0.00 USD | |
| 20 Feb 2026 | GRANT_AWARD | Caribou Biosciences, Inc. | 247,500 | 0.00 USD | deriv |
| 29 Jan 2025 | PURCHASE | Caribou Biosciences, Inc. | 17,360 | 1.42 USD | first after silence |
| 10 Jan 2025 | GRANT_AWARD | Caribou Biosciences, Inc. | 300,000 | 0.00 USD | deriv |
| 01 Jan 2024 | GRANT_AWARD | CODEXIS, INC. | 52,350 | 0.00 USD | |
| 01 Jan 2024 | GRANT_AWARD | CODEXIS, INC. | 314,125 | 0.00 USD | deriv |
| 08 Sept 2023 | PURCHASE | CODEXIS, INC. | 11,650 | 1.70 USD | first after silence |
| 10 Feb 2023 | GRANT_AWARD | CODEXIS, INC. | 111,791 | 0.00 USD | |
| 10 Feb 2023 | GRANT_AWARD | CODEXIS, INC. | 372,637 | 0.00 USD | deriv |
| 14 Mar 2022 | SALE | Celladon Corp | 2,266 | 5.60 USD | |
| 11 Mar 2022 | GRANT_AWARD | Celladon Corp | 24,000 | 0.00 USD | |
| 11 Mar 2022 | GRANT_AWARD | Celladon Corp | 143,000 | 0.00 USD | deriv |
| 29 Jul 2021 | GRANT_AWARD | Celladon Corp | 30,000 | 0.00 USD | deriv |
| 10 May 2021 | GRANT_AWARD | Celladon Corp | 87,000 | 0.00 USD | deriv |
| 12 Mar 2021 | GRANT_AWARD | Celladon Corp | 16,250 | 0.00 USD | |
| 12 Mar 2021 | GRANT_AWARD | Celladon Corp | 97,500 | 0.00 USD | deriv |
| 05 Mar 2020 | GRANT_AWARD | Celladon Corp | 229 | 7.31 USD | |
| 12 Mar 2020 | GRANT_AWARD | Celladon Corp | 65,000 | 0.00 USD | deriv |
| 05 Sept 2019 | GRANT_AWARD | Celladon Corp | 149 | 9.37 USD | |
| 22 Apr 2019 | PURCHASE | Celladon Corp | 1,250 | 11.08 USD | |
| 03 Jan 2019 | GRANT_AWARD | Celladon Corp | 90,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 29 Jan 2025.